Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease

Jørgensen et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69cdfe8c3d84e1f5ff46c484 — DOI: https://doi.org/10.1056/nejmoa1308027

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans.· 1991 · 208 citations
2. Lipoprotein Genotype and Conserved Pathway for Exceptional Longevity in Humans· 2006 · 222 citations
3. Pre-mRNA splicing and human disease· 2003 · 1,260 citations
4. Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families· 2013 · 23 citations
5. Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production· 2012 · 97 citations